DOI: 10.21276/ajptr
Tue, 19 Feb 2019

Development and Optimization of Immediate Release Pellets for Combined Dose Therapy.

S. P. Chaudhari 1*, R. R. Uttarwar1, P.M.Chaudhari1

1.Padm. Dr. D Y Patil College of Pharmacy,Akurdi Pune, Savitribai Phule Pune University, Maharashtra, India


The study was undertaken with an aim to improve the efficacy and reduce the adverse effect of drug, by combination therapy of  Diltiazem HCL and Quercetin dihydrate. In the present research 22 formulations were developed using design expert software with response surface methodology. In which the effect of superdisintegrant, type of superdisintegrant, effect of diluents, formation of solid dispersion studied for their in vitro release  from pellets. The result depicted that the formulation containing superdisintegrant crospovidone, diluent lactose and presence of surfactant  showed good disintegration time and in vitro drug release.

Key words: Diltiazem HCL, Quercetin, Pellets, Immediate release

[PDF]   Viewed: 653   Downloaded: 98
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter